Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDARUBICIN for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where IDARUBICIN was used for Lymphoma.

Most Reported Side Effects for IDARUBICIN

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 758 15.1% 94 414
Off label use 400 7.9% 109 96
Neutropenia 383 7.6% 93 137
Pyrexia 313 6.2% 58 160
Thrombocytopenia 293 5.8% 52 93
Drug ineffective 291 5.8% 120 117
Sepsis 289 5.7% 123 150
Pancytopenia 286 5.7% 73 93
Pneumonia 239 4.7% 91 121
Septic shock 227 4.5% 129 143
Acute myeloid leukaemia 216 4.3% 111 70
Death 214 4.3% 214 15
Myelosuppression 208 4.1% 14 104
Product use in unapproved indication 177 3.5% 53 28
Mucosal inflammation 161 3.2% 18 53

Other Indications for IDARUBICIN

Acute myeloid leukaemia (2,427) Acute promyelocytic leukaemia (481) Acute lymphocytic leukaemia (390) Product used for unknown indication (243) Chemotherapy (158) Myelodysplastic syndrome (103) Acute leukaemia (85) Non-hodgkin's lymphoma (68) Acute monocytic leukaemia (46) B-cell type acute leukaemia (45)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

IDARUBICIN Full Profile All Lymphoma Drugs IDARUBICIN Demographics IDARUBICIN Timeline